Reneo Pharmaceuticals

Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Their goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria…More work, preserving muscle function and preventing muscle injury, weakness and wasting. They are currently advancing a novel molecule into several diseases. Their experienced team of drug development experts, who have collaborated in many successful programs, are dedicated and passionate about finding effective therapies for these complex rare diseases.